16.02.2021Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model

Press Release
25.01.2021Iterum Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Oral Sulopenem

Press Release
05.01.2021Aura Biosciences Appoints David Johnson to Its Board of Directors

Press Release
22.10.2020F2G Receives Second US FDA Breakthrough Therapy Designation for Olorofim

Press Release
13.10.2020Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A drugs

Press Release
02.09.2020Highlight Therapeutics announces first patient dosed in Phase IIa study in liver metastasis

Press Release
12.08.2020PIC Therapeutics Appoints Dr. Katherine Bowdish as Chief Executive Officer

Press Release
12.08.2020F2G Closes US$60.8 Million Financing to fund late stage development of novel mechanism antifungal agent

Press Release
11.08.2020Advent Life Sciences announces sale of its portfolio Company KaNDy Therapeutics to Bayer AG for USD 425M upfront plus USD 450M in potential development milestones followed by further potential commercial milestones.

Press Release
06.08.2020Acutus Medical Announces Pricing of Initial Public Offering

Press Release